miR-133b targets NCAPH to promote β-catenin degradation and reduce cancer stem cell maintenance in non-small cell lung cancer

被引：0
|
作者：
Qiuxia Xiong
Liping Jiang
Kun Liu
Xiulin Jiang
Baiyang Liu
Yulin Shi
Dating Cheng
Yong Duan
Cuiping Yang
Yongbin Chen
机构：
[1] the First Affiliated Hospital of Kunming Medical University,Department of Clinical Laboratory
[2] Kunming Institute of Zoology,Key Laboratory of Animal Models and Human Disease Mechanisms of Chinese Academy of Sciences & Yunnan Province
[3] Chinese Academy of Sciences,Center for Excellence in Animal Evolution and Genetics
来源：
Signal Transduction and Targeted Therapy | / 6卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] miR-133b targets NCAPH to promote β-catenin degradation and reduce cancer stem cell maintenance in non-small cell lung cancer
    Xiong, Qiuxia
    Jiang, Liping
    Liu, Kun
    Jiang, Xiulin
    Liu, Baiyang
    Shi, Yulin
    Cheng, Dating
    Duan, Yong
    Yang, Cuiping
    Chen, Yongbin
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2021, 6 (01)
  • [2] miR-133b Inhibits Cell Growth, Migration, and Invasion by Targeting MMP9 in Non-Small Cell Lung Cancer
    Zhen, Yan
    Liu, Jia
    Huang, Yujie
    Wang, Yajun
    Li, Wen
    Wu, Jun
    ONCOLOGY RESEARCH, 2017, 25 (07) : 1109 - 1116
  • [3] CD133 is a temporary marker of cancer stem cells in small cell lung cancer, but not in non-small cell lung cancer
    Cui, Fei
    Wang, Jian
    Chen, Duan
    Chen, Yi-Jiang
    ONCOLOGY REPORTS, 2011, 25 (03) : 701 - 708
  • [4] Forkhead box L2 is a target of miR-133b and plays an important role in the pathogenesis of non-small cell lung cancer
    Li, Juan
    Gao, Lirong
    Wang, Anqi
    Qian, Huiwen
    Zhu, Jianjie
    Ji, Shundong
    Chen, Jun
    Liu, Zeyi
    Ji, Cheng
    CANCER MEDICINE, 2023, 12 (08): : 9826 - 9842
  • [5] Higher expression of miR-133b is associated with better efficacy of erlotinib as the second or third line in non-small cell lung cancer patients
    Bisagni, Alessandra
    Pagano, Maria
    Maramotti, Sally
    Zanelli, Francesca
    Bonacini, Martina
    Tagliavini, Elena
    Braglia, Luca
    Paci, Massimiliano
    Mozzarelli, Andrea
    Croci, Stefania
    PLOS ONE, 2018, 13 (04):
  • [6] β-catenin in non-small cell lung cancer (NSCLC)
    Swinson, DEB
    Lolljee, J
    Edwards, JG
    Jones, JL
    Cox, G
    Richardson, D
    O'Byrne, KJ
    BRITISH JOURNAL OF CANCER, 2002, 86 : S59 - S60
  • [7] TLR9 is a Cancer Stem Cell Maintenance Marker in Non-small Cell Lung Cancer
    Wu, Fengying
    Shan, Shan
    Han, Yang
    Ren, Tao
    CHEST, 2016, 149 (04) : 323A - 323A
  • [8] Immunotherapeutic targets in non-small cell lung cancer
    Sadeghirad, Habib
    Bahrami, Tayyeb
    Layeghi, Sepideh M.
    Yousefi, Hassan
    Rezaei, Meysam
    Hosseini-Fard, Seyed R.
    Radfar, Payar
    Warkiani, Majid E.
    O'Byrne, Ken
    Kulasinghe, Arutha
    IMMUNOLOGY, 2023, 168 (02) : 256 - 272
  • [9] Emerging Targets in Non-Small Cell Lung Cancer
    Liu, Louisa
    Soler, Joshua
    Reckamp, Karen L.
    Sankar, Kamya
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (18)
  • [10] New Targets in Non-Small Cell Lung Cancer
    Park, Soo J.
    More, Soham
    Murtuza, Ayesha
    Woodward, Brian D.
    Husain, Hatim
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2017, 31 (01) : 113 - +
12345